Insider selling
Traded Sep 22 · filed 58 days laterNot reported under a pre-arranged trading plan
A major shareholder of Bioaffinity Technologies sold $61K of Bioaffinity Technologies shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 28, 2026 · Filed Nov 19, 2026
A major shareholder of Bioaffinity Technologies paid $16 out of pocket for Bioaffinity Technologies shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$16
Shares × reported transaction price
<$25K
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
HRT FINANCIAL LP, 10% owner's past purchases, 90 days after disclosure: 75 buys, median −73.7 pts vs S&P 500, beat it 7 of 75 times. Past results, not a forecast.
No
Compared with 5 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
52 days after results of Aug 7, 2026, 39 days before results of Nov 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $7.41 on Sep 28, 2026, 63% above its 52-week low and 90% below its high, after a 23% rise over the previous 30 trading days
52-week range $4.56 (Aug 31, 2026) to $71.10 (Mar 26, 2026), 4% of the way up, from 244 adjusted closes. 30 trading days earlier: $6.03 on Aug 14, 2026. Describes the past only, not a forecast
RSI 48, 65% under its 200-day average, 8% under its 50-day average, 90% below the 52-week high, 20-day volatility 388% a year, against the S&P 500: +47 points over 1 month, −42 points over 3 months, −108 points over 6 months
From the adjusted closes up to Sep 28, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider selling
Traded Sep 22 · filed 58 days laterNot reported under a pre-arranged trading plan
A major shareholder of Bioaffinity Technologies sold $61K of Bioaffinity Technologies shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Sep 23 · filed 57 days laterNot reported under a pre-arranged trading plan
A major shareholder of Bioaffinity Technologies sold $88K of Bioaffinity Technologies shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Sep 23 · filed 57 days laterNot reported under a pre-arranged trading plan
A major shareholder of Bioaffinity Technologies sold $88K of Bioaffinity Technologies shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.